The emerging approach of the medication represents a significant breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – leading to enhanced glucose regulation and possible weight reduction. Experts are … Read More